OVERVIEW
The market for breast lesion localization methods is projected to reach USD 607 million by 2024, growing over the forecast period at a CAGR of 6.12%. This market’s growth is driven by factors such as rising breast cancer incidence, increasing number of breast cancer surgeries, increasing awareness of early breast cancer detection.
TABLE OF CONTENT
1 Global Breast Lesion Localization Methods Market
1.1 Study Pharmaceutical Drug Delivery Market
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Breast Lesion Localization Methods Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Breast Lesion Localization Methods Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Breast Lesion Localization Methods Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Breast Lesion Localization Methods Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Breast Lesion Localization Methods Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Breast Lesion Localization Methods Market – By Type (Market Size – & million/billion)
8.1 Wire Localization
8.2 Radioisotope Localization
8.3 Magnetic Localization
8.4 Electromagnetic Localization
8.5 Other
9 Global Breast Lesion Localization Methods Market – By Usage
9.1 Tumor Identification
9.2 Sentinel Lymph Node Identification
10 Global Breast Lesion Localization Methods Market – By Technique
10.1 Fine-Needle Aspiration Biopsy
10.2 Core Needle Biopsy
10.3 Image Guided Biopsy
10.4 Surgical Biopsy
11 Global Breast Lesion Localization Methods Market – By End-User
11.1 Providers
11.1.1 Community Clinics
11.1.2 Hospitals
11.1.3 Private Practices
11.2 Payers
11.3 Patients
12 Global Breast Lesion Localization Methods Market – By Geography (Market Size – &
million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa
13 Global Breast Lesion Localization Methods Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships
14 Global Breast Lesion Localization Methods Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 B.D. Company
14.3 Cianna Medical
14.4 Endomagnetics
14.5 SOMATEX Medical Technologies
14.6 Cook Medical
14.7 Cianna Medical
14.8 Leica Biosystems
14.9 Isoaid, LLC
14.10 Surgiceye GmbH
14.11 Ranfac Corporation
14.12 Company 11 & more
15 Global Breast Lesion Localization Methods Market – Appendix
15.1 Sources
15.2 Abbreviations